NeoGenomics stock down after leadership transition (NEO:NASDAQ)
· seekingalpha.com
NeoGenomics (NEO) stock drops after the CEO shakeup and the Q3 2026 preannouncement that, however, exceeded the consensus. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...